Articles related to OBESITY/WEIGHT MANAGEMENT

AABP represents a significant yet under-recognized consequence of obesity, requiring a multidisciplinary treatment strategy that transcends conventional weight loss advice and addresses the intricate psychological and physical needs of affected individuals.

Recent studies reveal that adding ezetimibe to lower-intensity statin therapy is as effective as high-intensity statin therapy alone in preventing major cardiovascular events, offering a new approach to lipid management in patients intolerant to high-intensity statins.

This study suggests that a positive approach, presenting weight loss treatment as an opportunity, may be more effective in encouraging patients to take up treatment and achieve weight loss.

The Yale Food Addiction Scale (YFAS) identified a prevalence of food addiction reaching 32% in people with obesity having bariatric surgery.

Stay informed about the potential risks associated with popular weight loss drugs. Ensure patient safety by monitoring for symptoms of depression and suicidal ideation.

New reports and studies are raising concerns about the gastrointestinal safety of semaglutide-containing medications; clinicians are advised to exercise caution and monitor patients for symptoms of gastroparesis.